N/A
N=26
Exploring Immunosuppressant Medication Adherence in Kidney Transplant Patients
Adherence, Medication · Transplantation, Kidney
Bottom Line
View on ClinicalTrials.gov: NCT03977051 ↗Enrolled (actual)
26
Serious AEs
0.0%
Results posted
Apr 2024
Primary outcome: Primary: Number of Kidney Transplant Patients Who Expressed an Understanding of the Term Immunosuppression Medication Adherence and the Importance Immunosuppression Medication Adherence Post Transplant — 19; 19 Participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Focus group (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Imperial College London
- Primary completion
- Jun 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Kidney Transplant Patients Who Expressed an Understanding of the Term Immunosuppression Medication Adherence and the Importance Immunosuppression Medication Adherence Post Transplant |
19; 19 | — |
| PRIMARY Number of Kidney Transplant Patients Who Identified Interventions to Support Immunosuppressant Medication Adherence |
14; 26; 15 | — |
| PRIMARY Number of Patients Who Identify Barriers to Immunosuppression Medication Adherence |
6; 6; 1 | — |
Summary
To describe the beliefs, understanding and experience of immunosuppressant medication adherence in our current transplant patient population through a series of patient focus groups
Eligibility Criteria
Inclusion Criteria
- Kidney transplant recipients transplanted and under the active follow up of ICRTC.
- Speak and understand English
- 18 years and above
Exclusion Criteria
- Unable to speak and understand English
- Below 18 years
Data sourced from ClinicalTrials.gov (NCT03977051). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.